Table of Content

1 Meropenem Injection Market Overview
1.1 Product Overview and Scope of Meropenem Injection
1.2 Meropenem Injection Segment by Type
1.2.1 Global Meropenem Injection Market Value Comparison by Type (2024-2034)
1.2.2 0.25g/vial
1.2.3 0.5g/vial
1.2.4 1g/vial
1.3 Meropenem Injection Segment by Application
1.3.1 Global Meropenem Injection Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Others
1.4 Global Meropenem Injection Market Size Estimates and Forecasts
1.4.1 Global Meropenem Injection Revenue 2018-2034
1.4.2 Global Meropenem Injection Sales 2018-2034
1.4.3 Global Meropenem Injection Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Meropenem Injection Market Competition by Manufacturers
2.1 Global Meropenem Injection Sales Market Share by Manufacturers (2018-2024)
2.2 Global Meropenem Injection Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Meropenem Injection Average Price by Manufacturers (2018-2024)
2.4 Global Meropenem Injection Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Meropenem Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Meropenem Injection, Product Type & Application
2.7 Meropenem Injection Market Competitive Situation and Trends
2.7.1 Meropenem Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Meropenem Injection Players Market Share by Revenue
2.7.3 Global Meropenem Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Meropenem Injection Retrospective Market Scenario by Region
3.1 Global Meropenem Injection Market Size by Region: 2018 Versus 2022 Versus 2034
3.2 Global Meropenem Injection Global Meropenem Injection Sales by Region: 2018-2034
3.2.1 Global Meropenem Injection Sales by Region: 2018-2024
3.2.2 Global Meropenem Injection Sales by Region: 2024-2034
3.3 Global Meropenem Injection Global Meropenem Injection Revenue by Region: 2018-2034
3.3.1 Global Meropenem Injection Revenue by Region: 2018-2024
3.3.2 Global Meropenem Injection Revenue by Region: 2024-2034
3.4 North America Meropenem Injection Market Facts & Figures by Country
3.4.1 North America Meropenem Injection Market Size by Country: 2018 VS 2022 VS 2034
3.4.2 North America Meropenem Injection Sales by Country (2018-2034)
3.4.3 North America Meropenem Injection Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Meropenem Injection Market Facts & Figures by Country
3.5.1 Europe Meropenem Injection Market Size by Country: 2018 VS 2022 VS 2034
3.5.2 Europe Meropenem Injection Sales by Country (2018-2034)
3.5.3 Europe Meropenem Injection Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Meropenem Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Meropenem Injection Market Size by Country: 2018 VS 2022 VS 2034
3.6.2 Asia Pacific Meropenem Injection Sales by Country (2018-2034)
3.6.3 Asia Pacific Meropenem Injection Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Meropenem Injection Market Facts & Figures by Country
3.7.1 Latin America Meropenem Injection Market Size by Country: 2018 VS 2022 VS 2034
3.7.2 Latin America Meropenem Injection Sales by Country (2018-2034)
3.7.3 Latin America Meropenem Injection Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Meropenem Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Meropenem Injection Market Size by Country: 2018 VS 2022 VS 2034
3.8.2 Middle East and Africa Meropenem Injection Sales by Country (2018-2034)
3.8.3 Middle East and Africa Meropenem Injection Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Meropenem Injection Sales by Type (2018-2034)
4.1.1 Global Meropenem Injection Sales by Type (2018-2024)
4.1.2 Global Meropenem Injection Sales by Type (2024-2034)
4.1.3 Global Meropenem Injection Sales Market Share by Type (2018-2034)
4.2 Global Meropenem Injection Revenue by Type (2018-2034)
4.2.1 Global Meropenem Injection Revenue by Type (2018-2024)
4.2.2 Global Meropenem Injection Revenue by Type (2024-2034)
4.2.3 Global Meropenem Injection Revenue Market Share by Type (2018-2034)
4.3 Global Meropenem Injection Price by Type (2018-2034)
5 Segment by Application
5.1 Global Meropenem Injection Sales by Application (2018-2034)
5.1.1 Global Meropenem Injection Sales by Application (2018-2024)
5.1.2 Global Meropenem Injection Sales by Application (2024-2034)
5.1.3 Global Meropenem Injection Sales Market Share by Application (2018-2034)
5.2 Global Meropenem Injection Revenue by Application (2018-2034)
5.2.1 Global Meropenem Injection Revenue by Application (2018-2024)
5.2.2 Global Meropenem Injection Revenue by Application (2024-2034)
5.2.3 Global Meropenem Injection Revenue Market Share by Application (2018-2034)
5.3 Global Meropenem Injection Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Meropenem Injection Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Pfizer Meropenem Injection Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 AuroMedics
6.2.1 AuroMedics Corporation Information
6.2.2 AuroMedics Description and Business Overview
6.2.3 AuroMedics Meropenem Injection Sales, Revenue and Gross Margin (2018-2024)
6.2.4 AuroMedics Meropenem Injection Product Portfolio
6.2.5 AuroMedics Recent Developments/Updates
6.3 Sandoz
6.3.1 Sandoz Corporation Information
6.3.2 Sandoz Description and Business Overview
6.3.3 Sandoz Meropenem Injection Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Sandoz Meropenem Injection Product Portfolio
6.3.5 Sandoz Recent Developments/Updates
6.4 Amneal Pharmaceuticals
6.4.1 Amneal Pharmaceuticals Corporation Information
6.4.2 Amneal Pharmaceuticals Description and Business Overview
6.4.3 Amneal Pharmaceuticals Meropenem Injection Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Amneal Pharmaceuticals Meropenem Injection Product Portfolio
6.4.5 Amneal Pharmaceuticals Recent Developments/Updates
6.5 Sumitomo Dainippon Pharma
6.5.1 Sumitomo Dainippon Pharma Corporation Information
6.5.2 Sumitomo Dainippon Pharma Description and Business Overview
6.5.3 Sumitomo Dainippon Pharma Meropenem Injection Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Sumitomo Dainippon Pharma Meropenem Injection Product Portfolio
6.5.5 Sumitomo Dainippon Pharma Recent Developments/Updates
6.6 Fresenius Kabi
6.6.1 Fresenius Kabi Corporation Information
6.6.2 Fresenius Kabi Description and Business Overview
6.6.3 Fresenius Kabi Meropenem Injection Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Fresenius Kabi Meropenem Injection Product Portfolio
6.6.5 Fresenius Kabi Recent Developments/Updates
6.7 Mylan
6.6.1 Mylan Corporation Information
6.6.2 Mylan Description and Business Overview
6.6.3 Mylan Meropenem Injection Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Mylan Meropenem Injection Product Portfolio
6.7.5 Mylan Recent Developments/Updates
6.8 Sagent Pharmaceuticals
6.8.1 Sagent Pharmaceuticals Corporation Information
6.8.2 Sagent Pharmaceuticals Description and Business Overview
6.8.3 Sagent Pharmaceuticals Meropenem Injection Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Sagent Pharmaceuticals Meropenem Injection Product Portfolio
6.8.5 Sagent Pharmaceuticals Recent Developments/Updates
6.9 Bionova Scientific
6.9.1 Bionova Scientific Corporation Information
6.9.2 Bionova Scientific Description and Business Overview
6.9.3 Bionova Scientific Meropenem Injection Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Bionova Scientific Meropenem Injection Product Portfolio
6.9.5 Bionova Scientific Recent Developments/Updates
6.10 Macleods Pharmaceuticals
6.10.1 Macleods Pharmaceuticals Corporation Information
6.10.2 Macleods Pharmaceuticals Description and Business Overview
6.10.3 Macleods Pharmaceuticals Meropenem Injection Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Macleods Pharmaceuticals Meropenem Injection Product Portfolio
6.10.5 Macleods Pharmaceuticals Recent Developments/Updates
6.11 Johnlee Pharmaceuticals
6.11.1 Johnlee Pharmaceuticals Corporation Information
6.11.2 Johnlee Pharmaceuticals Meropenem Injection Description and Business Overview
6.11.3 Johnlee Pharmaceuticals Meropenem Injection Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Johnlee Pharmaceuticals Meropenem Injection Product Portfolio
6.11.5 Johnlee Pharmaceuticals Recent Developments/Updates
6.12 Xinya Pharm
6.12.1 Xinya Pharm Corporation Information
6.12.2 Xinya Pharm Meropenem Injection Description and Business Overview
6.12.3 Xinya Pharm Meropenem Injection Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Xinya Pharm Meropenem Injection Product Portfolio
6.12.5 Xinya Pharm Recent Developments/Updates
6.13 PKU HealthCare
6.13.1 PKU HealthCare Corporation Information
6.13.2 PKU HealthCare Meropenem Injection Description and Business Overview
6.13.3 PKU HealthCare Meropenem Injection Sales, Revenue and Gross Margin (2018-2024)
6.13.4 PKU HealthCare Meropenem Injection Product Portfolio
6.13.5 PKU HealthCare Recent Developments/Updates
6.14 United Laboratories
6.14.1 United Laboratories Corporation Information
6.14.2 United Laboratories Meropenem Injection Description and Business Overview
6.14.3 United Laboratories Meropenem Injection Sales, Revenue and Gross Margin (2018-2024)
6.14.4 United Laboratories Meropenem Injection Product Portfolio
6.14.5 United Laboratories Recent Developments/Updates
6.15 CSPC Group
6.15.1 CSPC Group Corporation Information
6.15.2 CSPC Group Meropenem Injection Description and Business Overview
6.15.3 CSPC Group Meropenem Injection Sales, Revenue and Gross Margin (2018-2024)
6.15.4 CSPC Group Meropenem Injection Product Portfolio
6.15.5 CSPC Group Recent Developments/Updates
6.16 Zhejiang Hisun Pharmaceutical
6.16.1 Zhejiang Hisun Pharmaceutical Corporation Information
6.16.2 Zhejiang Hisun Pharmaceutical Meropenem Injection Description and Business Overview
6.16.3 Zhejiang Hisun Pharmaceutical Meropenem Injection Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Zhejiang Hisun Pharmaceutical Meropenem Injection Product Portfolio
6.16.5 Zhejiang Hisun Pharmaceutical Recent Developments/Updates
6.17 Luoxin Pharmaceutical
6.17.1 Luoxin Pharmaceutical Corporation Information
6.17.2 Luoxin Pharmaceutical Meropenem Injection Description and Business Overview
6.17.3 Luoxin Pharmaceutical Meropenem Injection Sales, Revenue and Gross Margin (2018-2024)
6.17.4 Luoxin Pharmaceutical Meropenem Injection Product Portfolio
6.17.5 Luoxin Pharmaceutical Recent Developments/Updates
6.18 Hainan Haiyao Co., Ltd.
6.18.1 Hainan Haiyao Co., Ltd. Corporation Information
6.18.2 Hainan Haiyao Co., Ltd. Meropenem Injection Description and Business Overview
6.18.3 Hainan Haiyao Co., Ltd. Meropenem Injection Sales, Revenue and Gross Margin (2018-2024)
6.18.4 Hainan Haiyao Co., Ltd. Meropenem Injection Product Portfolio
6.18.5 Hainan Haiyao Co., Ltd. Recent Developments/Updates
6.19 Shenzhen Haibin Pharmaceutical
6.19.1 Shenzhen Haibin Pharmaceutical Corporation Information
6.19.2 Shenzhen Haibin Pharmaceutical Meropenem Injection Description and Business Overview
6.19.3 Shenzhen Haibin Pharmaceutical Meropenem Injection Sales, Revenue and Gross Margin (2018-2024)
6.19.4 Shenzhen Haibin Pharmaceutical Meropenem Injection Product Portfolio
6.19.5 Shenzhen Haibin Pharmaceutical Recent Developments/Updates
6.20 Chongqin Shenghuaxi
6.20.1 Chongqin Shenghuaxi Corporation Information
6.20.2 Chongqin Shenghuaxi Meropenem Injection Description and Business Overview
6.20.3 Chongqin Shenghuaxi Meropenem Injection Sales, Revenue and Gross Margin (2018-2024)
6.20.4 Chongqin Shenghuaxi Meropenem Injection Product Portfolio
6.20.5 Chongqin Shenghuaxi Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Meropenem Injection Industry Chain Analysis
7.2 Meropenem Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Meropenem Injection Production Mode & Process
7.4 Meropenem Injection Sales and Marketing
7.4.1 Meropenem Injection Sales Channels
7.4.2 Meropenem Injection Distributors
7.5 Meropenem Injection Customers
8 Meropenem Injection Market Dynamics
8.1 Meropenem Injection Industry Trends
8.2 Meropenem Injection Market Drivers
8.3 Meropenem Injection Market Challenges
8.4 Meropenem Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Meropenem Injection Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Meropenem Injection Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Meropenem Injection Market Competitive Situation by Manufacturers in 2022
Table 4. Global Meropenem Injection Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Meropenem Injection Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Meropenem Injection Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Meropenem Injection Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Meropenem Injection Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Meropenem Injection, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Meropenem Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Meropenem Injection, Product Type & Application
Table 12. Global Key Manufacturers of Meropenem Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Meropenem Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meropenem Injection as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Meropenem Injection Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 17. Global Meropenem Injection Sales by Region (2018-2024) & (K Units)
Table 18. Global Meropenem Injection Sales Market Share by Region (2018-2024)
Table 19. Global Meropenem Injection Sales by Region (2024-2034) & (K Units)
Table 20. Global Meropenem Injection Sales Market Share by Region (2024-2034)
Table 21. Global Meropenem Injection Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Meropenem Injection Revenue Market Share by Region (2018-2024)
Table 23. Global Meropenem Injection Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Meropenem Injection Revenue Market Share by Region (2024-2034)
Table 25. North America Meropenem Injection Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 26. North America Meropenem Injection Sales by Country (2018-2024) & (K Units)
Table 27. North America Meropenem Injection Sales by Country (2024-2034) & (K Units)
Table 28. North America Meropenem Injection Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Meropenem Injection Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Meropenem Injection Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Meropenem Injection Sales by Country (2018-2024) & (K Units)
Table 32. Europe Meropenem Injection Sales by Country (2024-2034) & (K Units)
Table 33. Europe Meropenem Injection Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Meropenem Injection Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Meropenem Injection Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Meropenem Injection Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Meropenem Injection Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Meropenem Injection Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Meropenem Injection Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Meropenem Injection Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Meropenem Injection Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Meropenem Injection Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Meropenem Injection Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Meropenem Injection Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Meropenem Injection Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Meropenem Injection Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Meropenem Injection Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Meropenem Injection Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Meropenem Injection Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Meropenem Injection Sales (K Units) by Type (2018-2024)
Table 51. Global Meropenem Injection Sales (K Units) by Type (2024-2034)
Table 52. Global Meropenem Injection Sales Market Share by Type (2018-2024)
Table 53. Global Meropenem Injection Sales Market Share by Type (2024-2034)
Table 54. Global Meropenem Injection Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Meropenem Injection Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Meropenem Injection Revenue Market Share by Type (2018-2024)
Table 57. Global Meropenem Injection Revenue Market Share by Type (2024-2034)
Table 58. Global Meropenem Injection Price (US$/Unit) by Type (2018-2024)
Table 59. Global Meropenem Injection Price (US$/Unit) by Type (2024-2034)
Table 60. Global Meropenem Injection Sales (K Units) by Application (2018-2024)
Table 61. Global Meropenem Injection Sales (K Units) by Application (2024-2034)
Table 62. Global Meropenem Injection Sales Market Share by Application (2018-2024)
Table 63. Global Meropenem Injection Sales Market Share by Application (2024-2034)
Table 64. Global Meropenem Injection Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Meropenem Injection Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Meropenem Injection Revenue Market Share by Application (2018-2024)
Table 67. Global Meropenem Injection Revenue Market Share by Application (2024-2034)
Table 68. Global Meropenem Injection Price (US$/Unit) by Application (2018-2024)
Table 69. Global Meropenem Injection Price (US$/Unit) by Application (2024-2034)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Pfizer Meropenem Injection Product
Table 74. Pfizer Recent Developments/Updates
Table 75. AuroMedics Corporation Information
Table 76. AuroMedics Description and Business Overview
Table 77. AuroMedics Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. AuroMedics Meropenem Injection Product
Table 79. AuroMedics Recent Developments/Updates
Table 80. Sandoz Corporation Information
Table 81. Sandoz Description and Business Overview
Table 82. Sandoz Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Sandoz Meropenem Injection Product
Table 84. Sandoz Recent Developments/Updates
Table 85. Amneal Pharmaceuticals Corporation Information
Table 86. Amneal Pharmaceuticals Description and Business Overview
Table 87. Amneal Pharmaceuticals Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Amneal Pharmaceuticals Meropenem Injection Product
Table 89. Amneal Pharmaceuticals Recent Developments/Updates
Table 90. Sumitomo Dainippon Pharma Corporation Information
Table 91. Sumitomo Dainippon Pharma Description and Business Overview
Table 92. Sumitomo Dainippon Pharma Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Sumitomo Dainippon Pharma Meropenem Injection Product
Table 94. Sumitomo Dainippon Pharma Recent Developments/Updates
Table 95. Fresenius Kabi Corporation Information
Table 96. Fresenius Kabi Description and Business Overview
Table 97. Fresenius Kabi Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Fresenius Kabi Meropenem Injection Product
Table 99. Fresenius Kabi Recent Developments/Updates
Table 100. Mylan Corporation Information
Table 101. Mylan Description and Business Overview
Table 102. Mylan Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Mylan Meropenem Injection Product
Table 104. Mylan Recent Developments/Updates
Table 105. Sagent Pharmaceuticals Corporation Information
Table 106. Sagent Pharmaceuticals Description and Business Overview
Table 107. Sagent Pharmaceuticals Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Sagent Pharmaceuticals Meropenem Injection Product
Table 109. Sagent Pharmaceuticals Recent Developments/Updates
Table 110. Bionova Scientific Corporation Information
Table 111. Bionova Scientific Description and Business Overview
Table 112. Bionova Scientific Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Bionova Scientific Meropenem Injection Product
Table 114. Bionova Scientific Recent Developments/Updates
Table 115. Macleods Pharmaceuticals Corporation Information
Table 116. Macleods Pharmaceuticals Description and Business Overview
Table 117. Macleods Pharmaceuticals Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Macleods Pharmaceuticals Meropenem Injection Product
Table 119. Macleods Pharmaceuticals Recent Developments/Updates
Table 120. Johnlee Pharmaceuticals Corporation Information
Table 121. Johnlee Pharmaceuticals Description and Business Overview
Table 122. Johnlee Pharmaceuticals Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Johnlee Pharmaceuticals Meropenem Injection Product
Table 124. Johnlee Pharmaceuticals Recent Developments/Updates
Table 125. Xinya Pharm Corporation Information
Table 126. Xinya Pharm Description and Business Overview
Table 127. Xinya Pharm Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Xinya Pharm Meropenem Injection Product
Table 129. Xinya Pharm Recent Developments/Updates
Table 130. PKU HealthCare Corporation Information
Table 131. PKU HealthCare Description and Business Overview
Table 132. PKU HealthCare Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. PKU HealthCare Meropenem Injection Product
Table 134. PKU HealthCare Recent Developments/Updates
Table 135. United Laboratories Corporation Information
Table 136. United Laboratories Description and Business Overview
Table 137. United Laboratories Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. United Laboratories Meropenem Injection Product
Table 139. United Laboratories Recent Developments/Updates
Table 140. CSPC Group Corporation Information
Table 141. CSPC Group Description and Business Overview
Table 142. CSPC Group Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. CSPC Group Meropenem Injection Product
Table 144. CSPC Group Recent Developments/Updates
Table 145. Zhejiang Hisun Pharmaceutical Corporation Information
Table 146. Zhejiang Hisun Pharmaceutical Description and Business Overview
Table 147. Zhejiang Hisun Pharmaceutical Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. Zhejiang Hisun Pharmaceutical Meropenem Injection Product
Table 149. Zhejiang Hisun Pharmaceutical Recent Developments/Updates
Table 150. Luoxin Pharmaceutical Corporation Information
Table 151. Luoxin Pharmaceutical Description and Business Overview
Table 152. Luoxin Pharmaceutical Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 153. Luoxin Pharmaceutical Meropenem Injection Product
Table 154. Luoxin Pharmaceutical Recent Developments/Updates
Table 155. Hainan Haiyao Co., Ltd. Corporation Information
Table 156. Hainan Haiyao Co., Ltd. Description and Business Overview
Table 157. Hainan Haiyao Co., Ltd. Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 158. Hainan Haiyao Co., Ltd. Meropenem Injection Product
Table 159. Hainan Haiyao Co., Ltd. Recent Developments/Updates
Table 160. Shenzhen Haibin Pharmaceutical Corporation Information
Table 161. Shenzhen Haibin Pharmaceutical Description and Business Overview
Table 162. Shenzhen Haibin Pharmaceutical Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 163. Shenzhen Haibin Pharmaceutical Meropenem Injection Product
Table 164. Shenzhen Haibin Pharmaceutical Recent Developments/Updates
Table 165. Chongqin Shenghuaxi Corporation Information
Table 166. Chongqin Shenghuaxi Description and Business Overview
Table 167. Chongqin Shenghuaxi Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 168. Chongqin Shenghuaxi Meropenem Injection Product
Table 169. Chongqin Shenghuaxi Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Meropenem Injection Distributors List
Table 173. Meropenem Injection Customers List
Table 174. Meropenem Injection Market Trends
Table 175. Meropenem Injection Market Drivers
Table 176. Meropenem Injection Market Challenges
Table 177. Meropenem Injection Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Meropenem Injection
Figure 2. Global Meropenem Injection Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Meropenem Injection Market Share by Type in 2022 & 2034
Figure 4. 0.25g/vial Product Picture
Figure 5. 0.5g/vial Product Picture
Figure 6. 1g/vial Product Picture
Figure 7. Global Meropenem Injection Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Meropenem Injection Market Share by Application in 2022 & 2034
Figure 9. Hospital
Figure 10. Clinics
Figure 11. Others
Figure 12. Global Meropenem Injection Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 13. Global Meropenem Injection Market Size (2018-2034) & (US$ Million)
Figure 14. Global Meropenem Injection Sales (2018-2034) & (K Units)
Figure 15. Global Meropenem Injection Average Price (US$/Unit) & (2018-2034)
Figure 16. Meropenem Injection Report Years Considered
Figure 17. Meropenem Injection Sales Share by Manufacturers in 2022
Figure 18. Global Meropenem Injection Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Meropenem Injection Players: Market Share by Revenue in 2022
Figure 20. Meropenem Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Meropenem Injection Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Figure 22. North America Meropenem Injection Sales Market Share by Country (2018-2034)
Figure 23. North America Meropenem Injection Revenue Market Share by Country (2018-2034)
Figure 24. U.S. Meropenem Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 25. Canada Meropenem Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 26. Europe Meropenem Injection Sales Market Share by Country (2018-2034)
Figure 27. Europe Meropenem Injection Revenue Market Share by Country (2018-2034)
Figure 28. Germany Meropenem Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. France Meropenem Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. U.K. Meropenem Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Italy Meropenem Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Russia Meropenem Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. Asia Pacific Meropenem Injection Sales Market Share by Region (2018-2034)
Figure 34. Asia Pacific Meropenem Injection Revenue Market Share by Region (2018-2034)
Figure 35. China Meropenem Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. Japan Meropenem Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. South Korea Meropenem Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. India Meropenem Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Australia Meropenem Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Taiwan Meropenem Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Indonesia Meropenem Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Thailand Meropenem Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Malaysia Meropenem Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Philippines Meropenem Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Latin America Meropenem Injection Sales Market Share by Country (2018-2034)
Figure 46. Latin America Meropenem Injection Revenue Market Share by Country (2018-2034)
Figure 47. Mexico Meropenem Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Brazil Meropenem Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Argentina Meropenem Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Middle East & Africa Meropenem Injection Sales Market Share by Country (2018-2034)
Figure 51. Middle East & Africa Meropenem Injection Revenue Market Share by Country (2018-2034)
Figure 52. Turkey Meropenem Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. Saudi Arabia Meropenem Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. UAE Meropenem Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 55. Global Sales Market Share of Meropenem Injection by Type (2018-2034)
Figure 56. Global Revenue Market Share of Meropenem Injection by Type (2018-2034)
Figure 57. Global Meropenem Injection Price (US$/Unit) by Type (2018-2034)
Figure 58. Global Sales Market Share of Meropenem Injection by Application (2018-2034)
Figure 59. Global Revenue Market Share of Meropenem Injection by Application (2018-2034)
Figure 60. Global Meropenem Injection Price (US$/Unit) by Application (2018-2034)
Figure 61. Meropenem Injection Value Chain
Figure 62. Meropenem Injection Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed